The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Berinert 500 IU Powder and solvent for solution for injection/infusion.

CSL Behring GmbHPA0800/013/001

Main Information

Trade NameBerinert 500 IU Powder and solvent for solution for injection/infusion.
Active SubstancesC1 Esterase Inhibitor (Human)
Dosage FormPowder and solvent for solution for injection
Licence HolderCSL Behring GmbH
Licence NumberPA0800/013/001

Group Information

ATC CodeB06AC01 c1-inhibitor, plasma derived


License statusAuthorised
Licence Issued27/08/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back